No Data
Affluent Partners Changes Name to Baijin Life Science
AFFLUENTPARTNER (01466) has been renamed to "Bai Jin Life Sciences Holdings Limited".
AFFLUENTPARTNER (01466) announced that it will pass special resolutions at the Shareholder's extraordinary general meeting to be held on November 26, 2024.
The abbreviation of AFFLUENTPARTNER (01466.HK) shares will change effective from January 9.
Gelonghui reported on January 3 that AFFLUENTPARTNER (01466.HK) announced that starting from January 9, 2025, at 9:00 AM, the English and Chinese stock abbreviations for trading on the Hong Kong Stock Exchange will be changed from "AFFLUENTPARTNER" to "BAIJIN LIFE SCI" and from "钱唐控股" to "佰金生命科学" respectively.
AFFLUENTPARTNER (01466.HK) appoints Xie Chuncheng as a non-executive Director.
Gelonghui, December 23丨AFFLUENTPARTNER (01466.HK) announced that Xie Chuncheng has been appointed as a non-executive Director of the company, effective from December 23, 2024.
AFFLUENTPARTNER: 2024 Interim Report
格隆汇公告精选(Hong Kong stocks) | hkbn (01310.HK) received a tender offer from china mobile at a offer price of approximately 40.97% premium to the closing price on November 12th.
【Today's Focus】hkbn (01310.HK) received an acquisition offer from china mobile. The offer price is approximately 40.97% higher than the closing price on November 12. hkbn (01310.HK) announced that, pending the fulfillment of conditions or exemptions, CICC will represent the offeror, china mobile hong kong limited, to submit a voluntary conditional full cash offer to acquire all issued shares (excluding those already owned by the offeror and its concert parties), and will make appropriate arrangements for all sellers' loan notes and unvested restricted share units in accordance with rule 13 of the takeover code. The offer price is 5 cash per share.
